BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Novavax vaccine shows its chops
Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead being played...

More in BioWorld

BioWorld MedTech

Varian secures IDE for experimental cancer therapy trial
Varian Medical Systems Inc. received an investigational device exemption (IDE) from the U.S. FDA to start a clinical trial evaluating its new radiation therapy. The...

More in BioWorld MedTech

BioWorld Science

Tumors might be nudged to more treatable state
Researchers at the Institute for Cancer Research have demonstrated that in pancreatic tumors, the balance between a more aggressive mesenchymal and a less aggressive epithelial state is constantly in flux, depending on an interplay of different regulatory proteins.

More in BioWorld Science

BioWorld Asia

Sutro to develop immunostimulatory ADCs for Astellas targets in deal worth $1.3B
Astellas Pharma Inc. and Sutro Biopharma Inc. signed an exclusive global licensing deal under which Sutro will develop immunostimulatory antibody-drug conjugates (iADCs)...

More in BioWorld Asia

BioWorld Insider Podcast

As multidisciplinary care extends survival and improves the quality of life for people with amyotrophic lateral sclerosis (ALS), can a host of new ALS drugs vying to slow its progression make a difference? Join the BioWorld Insider podcast as we discuss what the future of medicine may hold for ALS patients.